MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors
- 1 May 1984
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 326 (1) , 36-44
- https://doi.org/10.1007/bf00518776
Abstract
The properties of MDL 72222 (1αH,3α,5αH-tropan-3-yl-3,5-dichlorobenzoate), a novel compound with potent and selective blocking actions at certain excitatory 5-hydroxytryptamine (5-HT) receptors on mammalian peripheral neurones, are described. On the rabbit isolated heart, MDL 72222 was a potent antagonist of responses mediated through the receptors for 5-HT present on the terminal sympathetic fibres. The threshold for antagonism was approximately 0.1 nM and the negative logarithm of the molar concentration of MDL 72222 which reduced the chronotropic response of the isolated rabbit heart to twice an ED50 of 5-HT to that of the ED50 was 9.27. MDL 72222 was also highly selective since responses to the nicotine receptor agonist, dimethylphenylpiperazinum iodine (DMPP), were inhibited only at concentrations more than 1000 times those necessary to inhibit 5-HT. In the anaesthetised rat, MDL 72222 produced marked blockade of the Bezold-Jarisch effect of 5-HT. Again, inhibition was selective since much higher doses of MDL 72222 failed to alter the response to electrical stimulation of the efferent vagus nerves. In contrast, MDL 72222 proved only a weak and essentially non-selective antagonist of responses mediated by the 5-HT M-receptor present on the cholinergic nerves of the guinea-pig ileum. MDL 72222 does not block smooth muscle contractile responses elicited by oxytocin or mediated through 5-HT D-receptors, muscarinic or nicotinic cholinoceptors or histamine H1-receptors except at relatively high concentrations. Similarly, in a number of radioligand binding assays carried out using brain tissue membranes, the displacing effects of MDL 72222 were absent or weak at sites identifying compounds with activity at α1, α2 or β-adrenoceptors, 5-HT1 or 5-HT2 receptors, benzodiazepine receptors or histamine H1-receptors. MDL 72222 is the first reported selective and potent antagonist of responses mediated through the 5-HT receptors present on the terminal sympathetic neurones of the rabbit heart and on the neurones subserving the afferent limb of the Bezold-Jarisch reflex. The compound should provide a useful means by which responses mediated through such sites can be distinguished.Keywords
This publication has 23 references indexed in Scilit:
- DIFFERENCES BETWEEN RECEPTORS FOR 5-HYDROXYTRYPTAMINE ON AUTONOMIC NEURONES REVEALED BY NOR-(–)-COCAINEJournal of Autonomic Pharmacology, 1983
- Assessment of ?Ca2+-antagonist? effects of drugs in K+-depolarized smooth muscleNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1982
- Neuronal 5-hydroxytryptamine receptors outside the central nervous systemLife Sciences, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Blockade of serotonin receptors on autonomic neurones by (−)-cocaine and some related compoundsEuropean Journal of Pharmacology, 1979
- Blockade of neuronal tryptamine receptors by metoclopramideEuropean Journal of Pharmacology, 1978
- MECHANISM OF THE INDIRECT SYMPATHOMIMETIC EFFECT OF 5‐HYDROXYTRYPTAMINE ON THE ISOLATED HEART OF THE RABBITBritish Journal of Pharmacology, 1976
- The hypotensive action of 5-hydroxytryptamine (5-HT) in anaesthetised and pithed ratsEuropean Journal of Pharmacology, 1968
- TWO KINDS OF TRYPTAMINE RECEPTORBritish Journal of Pharmacology and Chemotherapy, 1957
- pA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISMBritish Journal of Pharmacology and Chemotherapy, 1947